Clinical trials
Observational Pulmonary Disease, Chronic Obstructive trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Boehringer Ingelheim | 4 |
| Eurasian Association of Therapists | 4 |
| National Medical Research Center for Therapy and Preventive Medicine | 3 |
| I.M. Sechenov First Moscow State Medical University | 2 |
| Novosibirsk City Hospital #2 | 2 |
| Interregional Public Organization, Russian Respiratory Society | 1 |
| MedImmune LLC | 1 |
| Meshalkin Research Institute of Pathology of Circulation | 1 |
| Russian Federation of Anesthesiologists and Reanimatologists | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 29 |
| Asthma | 6 |
| Diabetes Mellitus | 5 |
| COVID-19 | 4 |
| Obesity | 4 |
| Atrial Fibrillation | 3 |
| Coronary Disease | 3 |
| Hypertension | 3 |
| Neoplasms | 3 |
| Overweight | 3 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.